Pfizer $2.3 Billion Fraudulent Marketing

GlaxoSmithKline Plead Guilty and Pay $3 Billion for Fraudulent Marketing and Failure to Report Safety Data

Johnson & Johnson Pay More Than $2.2 Billion in Criminal and Civil Investigations for Fraudulent Marketing and Kickbacks to Doctors and Pharmacists

Committee on Oversight and Reform Report on Emergent BioSolutions Uncovers Extensive Vaccine Manufacturing Failures and Deliberate Efforts to Hide Deficiencies

Merck Gardasil Clinical Trials: Gardasil Vaccine Lawsuit

Blood Money: Bayer’s Inventory of HIV Contaminated Blood Products and Third World Hemophilias

In Bed With Big Pharma: Corruption Fears As Report Finds US Doctors Received Record $12Bn In Pharma Payments In Past Decade

Parliamentary Assembly of the Council of Europe (PACE) Investigation of the World Health Organisation Motives for Declaring H1N1 a Pandemic (2010):
“On 11 June 2009, the World Health Organization (WHO) officially declared “Pandemic (H1N1) 2009”. The way in which the H1N1 influenza pandemic has been handled, not only by WHO, but also by the competent health authorities at the level of the European Union and at national level, gives rise to alarm. Some of the consequences of decisions taken and advice given are particularly troubling, as they led to distortion of priorities of public health services across Europe, waste of large sums of public money and also unjustified scares and fears about health risks faced by the European public at large.”

Pfizer-BioNTech Annual Report (PAGE 6):
“Our revenue depends heavily on sales of our COVID-19 vaccine, and our future revenues from our COVID-19 vaccine are uncertain. We may not be able to demonstrate sufficient efficacy or safety of our COVID-19 vaccine and/or variant-specific formulations to obtain permanent regulatory approval in the United States, the United Kingdom, the European Union, or other countries where it has been authorized for emergency use or granted conditional marketing approval. Significant adverse events may occur during our clinical trials or even after receiving regulatory approval, which could delay or terminate clinical trials, delay or prevent regulatory approval or market acceptance of any of our product candidates.”

Pfizer-BioNTech EU Contract:
“The Participating Member State further acknowledges that the long-term effects and efficacy of the Vaccine are not currently known and that there may be adverse effects of the Vaccine that are not currently known. Each Participating Member State shall indemnify and hold harmless the Contractor, their Affiliates, sub-contractors, licensors and sub-licensees, and officers, directors, employees and other agents and representatives of each (together, the “Indemnified Persons”) from and against any and all liabilities incurred.”

Senator Rand Paul Questions Moderna CEO Stéphane Bancel Over COVID-19 Vaccine Side Effects, “Mr. Bancel, Moderna recently paid NIH $400 million. Do you believe it creates a conflict of interest for the government employees who are making money now off of the vaccine to also be dictating the policy about how many times we have to take the vaccine?”

UK Parliament Select Committee on Health:
“The evidence to this inquiry indicated that, in recent years, large pharmaceutical companies have become ever more focused on a marketing-based approach. In our view, this is the source of many of the problems we have identified. Our over-riding concerns are about the volume, extent and intensity of the industry’s influence, not only on clinical medicine and research but also on patients, regulators, the media, civil servants and politicians. The regulatory system, the medical profession and Government have all failed to ensure that industry’s activities are more clearly allied to the interests of patients and the NHS.”

Pandemic Response and Recovery All-Party Parliamentary Group – Failings of the Yellow Card System (MHRA):
Prof. Carl Heneghan, Director of Centre for Evidence Based Medicine, “Under-reporting of adverse drug reactions to the Yellow Card system could be as high as 98%, meaning the ability to detect signals and assign causation is substantially hindered. Should the MHRA, our regulatory body, be primarily funded by fees derived from services to the pharmaceutical industry?”

MHRA awarded over £980,000 for collaboration with the Bill and Melinda Gates Foundation and the World Health Organisation

Dr. Maryanne Demasi, “Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of investigational medicines before they hit the market. But do they have sufficient independence from the companies they are meant to regulate?”

Medical royal colleges receive millions from drug and medical devices companies

UK 10 Year Partnership with Moderna

Revisiting financial conflicts of interest in FDA advisory committees:
“The Food and Drug Administration (FDA) Safety and Innovation Act has recently relaxed conflict-of-interest rules for FDA advisory committee members, but concerns remain about the influence of members’ financial relationships on the FDA’s drug approval process.”

FDA’s Revolving Door

Aaron Siri, Civil Litigation Attorney: Why Are Vaccine Manufacturers the Most Protected Companies in America?
Aaron Siri, Civil Litigation Attorney: How the Vaccine Paradigm Has Led to Medical Coercion and Conflicted Health Agencies

Dr. Peter Doshi – Marketing Vaccine By Marketing Disease:
“The cleverest aspect of the influenza marketing strategy surrounds the claim that “flu” and “influenza” are the same. All influenza is “flu,” but only one in six “flus” might be influenza. It’s no wonder so many people feel that “flu shots” don’t work: for most flus, they can’t.”

Dr. Lee D. Merritt: The Treatment of Viral Diseases – Has the Truth Been Suppressed for Decades?

Africa to Become Testing Ground for “Trust Stamp” Vaccine Record and Biometric Digital Payment System:
“The program, which was first launched in late 2018, will see Trust Stamp’s digital identity platform integrated into the GAVI-Mastercard “Wellness Pass,” a digital vaccination record and identity system that is also linked to Mastercard’s click-to-play system that powered by its AI and machine learning technology called NuData.”

CDC 2019 Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel (PAGE 40):
“Since no quantified virus isolates of the 2019-nCoV were available for CDC use at the time the test was developed and this study conducted, assays designed for detection of the 2019-nCoV RNA were tested with characterized stocks of in vitro transcribed full length RNA.”

Changes to CDC RT-PCR for SARS-CoV-2 Testing:
“After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only.”

COVID-19 Vaccine Efficacy and Effectiveness – The Elephant (NOT) in the Room:
“These considerations on efficacy and effectiveness are based on studies measuring prevention of mild to moderate COVID-19 infection; they were not designed to conclude on prevention of hospitalisation, severe disease, or death, or on prevention of infection and transmission potential. Assessing the suitability of vaccines must consider all indicators, and involve safety, deployability, availability, and costs.”

Guidance for the Prevention of COVID-19 Infections Among High-Risk Individuals in Urban Settings (Green Zones):
“The main feature of this approach is to create ‘green zones’–dedicated areas at either the household, extended family or neighbourhood level, in which high-risk individuals (the elderly and those with chronic, underlying conditions) are relocated temporarily, and have minimal contact with family members and other community members at lower risk of severe disease.”

Scientific Advisory Group for Emergencies (SAGE) – Options for Increasing Adherence to Social Distancing Measures:
“The perceived level of personal threat needs to be increased among those who are complacent, using hard-hitting emotional messaging.”

MINDSPACE – Influencing Behaviour Through Public Policy:
“This means that citizens may not fully realise that their behaviour is being changed or, at least, how it is being changed. Clearly, this opens government up to charges of manipulation.”

Belgian Flu Commissioner on Public Engagement – How to Work With Media to Mislead the Public

Dr. Peter Doshi, “Will covid-19 vaccines save lives? Current trials aren’t designed to tell us.”
Dr. David Bauer: Pfizer vaccine produces fewer key antibodies
Dr. Peter Hotez: Testimony regarding development of coronavirus vaccine and unique safety challenges
Dr. Reiner Fuellmich: German Corona Committee – Dr. David Martin
Dr. David Martin: Covid-19 was deliberately released on the populations by entities with intent

Dr. David Martin: The Fauci COVID-19 Dossier

Gain-of-Function Hall of Shame

FOI Documents on Origins of Covid-19 Gain-Of-Function Research and Biolabs

Dr. Wu Zunyou: They Didn’t Isolate The Virus (Chinese Center for Disease Control)
Congressman Matt Gaetz Exposes Taxpayer-Funded Wuhan Lab Experiments

In December 2002, after President George W. Bush appointed Dr. Anthony Fauci to lead the US bioweapons program, Fauci discussed acquiring knowledge about bioweapons from “Soviet Union defectors who had vast experience in the ways of biowarfare.”

Dr. Fauci Backed Controversial Wuhan Lab with U.S. Dollars for Risky Coronavirus Research

Dr. Fauci worked behind the scenes to cast doubt on Wuhan lab leak hypothesis

Dr. Fauci Head of Creation and Development for Bill Gates Vaccine Research Center

Dr. Fauci Leadership Council for Bill Gates Decade of Vaccines Collaboration

Research on Highly Pathogenic H5N1 Influenza Virus: The Way Forward
Dr. Fauci, “The voluntary moratorium on gain-of-function research related to the transmissibility of highly pathogenic H5N1 influenza virus should continue, pending the resolution of critical policy questions concerning the rationale for performing such experiments and how best to report their results.”

Dr. Francis Collins, Director National Institutes of Health – Statement on Funding Pause on Certain Types of Gain-of-Function Research:
“NIH has funded such studies because they help define the fundamental nature of human-pathogen interactions, enable the assessment of the pandemic potential of emerging infectious agents, and inform public health and preparedness efforts. These studies, however, also entail biosafety and biosecurity risks, which need to be understood better.”

Dr. Peter Daszak, President of EcoHealth Alliance, “To sustain the funding base beyond the crisis, we need to increase public understanding of the need for MCMs such as a pan-influenza or pan-coronavirus vaccine. A key driver is the media, and the economics follow the hype. We need to use that hype to our advantage to get to the real issues. Investors will respond if they see profit at the end of process.”

Senate Committee on Health Education, Labor and Pensions Minority Oversight Staff: An Analysis of the Origins of the COVID-19 Pandemic
“The EcoHealth Alliance NIH grants and DARPA grant proposals, in partnership with the WIV, sought to collect and conduct genetic recombination experiments on SARS-related coronaviruses with specific traits that made those viruses a “high-risk” for zoonotic spillover into animals and humans. SARS-CoV-2 shares many of the traits these researchers were interested in finding in SARS-related coronaviruses or interested in engineering such traits if they were not found naturally. Based on the analysis of the publicly available information, it appears reasonable to conclude that the COVID-19 pandemic was, more likely than not, the result of a research-related incident.”

A Proposed Oversight and Decision Mechanism for Creating and/or Researching Potential Pandemic Pathogens:
“The viruses that are the subject of the White House order include highly pathogenic Asian influenza viruses that can transmit disease from mammal to mammal by the respiratory route (airborne transmission). Such viruses have already been created in the laboratory, in particular but not limited to the laboratories of Ron Fouchier and Yoshihiro Kawaoka. If one of these viruses escaped a laboratory, it could seed a pandemic with thousands to millions of human fatalities. These are called GOF studies of concern by the National Science Advisory Board forBiosecurity (NSABB), or simply studies of concern.”

Methods for producing recombinant coronavirus (PATENT: US7279327B2)
“This invention was made possible with government support under grant numbers AI23946 and GM63228 from the National Institutes of Health. The United States government has certain rights to this invention. The present invention relates to methods of producing recombinant nidovirus vectors, particularly coronavirus vectors, and expressing heterologous genes from said vectors.”

Nano coronavirus recombinant vaccine taking graphene oxide as carrier (PATENT: CN112220919A)
“The invention discloses a brand-new vaccine development method based on a graphene oxide material serving as a framework for loading CpG molecules and recombinant proteins. Based on the technical platform, a new nano new crown vaccine is prepared by combining the recombinant protein of the RBD region of the Spike protein of the SAR-CoV-2.”

Forensic examination of Wuhan Institute of Virology COVID-19 patient specimens from December 2019 reveals gross contamination of the laboratory, including undisclosed research on a lethal BSL-4 pathogen.

A Bayesian analysis concludes beyond a reasonable doubt that SARS-CoV-2 is not a natural zoonosis but instead is laboratory derived

Leaked Grant Proposal Details High-Risk Coronavirus Research

NIH Documents Provide New Evidence U.S. Funded Gain-of-Function Research in Wuhan

U.S. Department of Defense issued a contract for ‘COVID-19 Research’ in Ukraine 3 months before Covid was known to even exist
U.S. Government Gain-of-Function Deliberative Process and Research Funding Pause on Selected Gain-of-Function Research Involving Influenza, MERS, and SARS Viruses
U.S. Department of Health and Human Services – Framework for Guiding Funding Decisions about Proposed Research Involving Enhanced Potential Pandemic Pathogens
Gain-of-Function Deliberative Process

Gain of Function Research

Project DEFUSE: Defusing the Threat of Bat-borne Coronaviruses

Global Pandemics: Gain-of-Function Research of Concern

EcoHealth Alliance: Understanding the Risk of Bat Coronavirus Emergence

Dr. Andrew Huff, Former Vice President of EcoHealth Alliance: The Truth About Wuhan

A New Approach to Evaluating the Risk–Benefit Equation for Dual-Use and Gain-of-Function Research of Concern
Methods and compositions for chimeric coronavirus spike proteins
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
Baric to lead $10 million NIH grant
NIAID renews 5 year grant for research on emerging viruses
DECEMBER 12, 2019 an agreement was signed (PAGE 105) that Dr. Ralph Baric of the University of North Carolina would receive “mRNA corona virus vaccine candidates developed and jointly-owned by NIAID and Moderna”

WUHAN Institute of Virology Lab press release about partnership with Department for International Development and Bill & Melinda Gates Foundation
Meet the world’s most powerful doctor: Bill Gates
Bill Gates and his coronavirus conflicts of interest
Journalism’s Gates keepers

Who Funds The WHO?

U.S. Philanthrocapitalism and the Global Health Agenda: The Rockefeller and Gates Foundations, Past and Present

Scroll to Top